Deep Apple Therapeutics
United States
unknown
unknown
Stage
1
Investors
About
Deep Apple Therapeutics applies structure-based virtual screening of ultra-large chemical libraries combined with deep learning models to accelerate small-molecule drug discovery. The company is pursuing discovery of oral therapeutics and has a collaboration with Novo Nordisk to develop cardiometabolic disease candidates.
Explore Deep Apple Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.